Results 121 to 130 of about 4,697 (156)

Clinical Safety Profile of Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukaemia: A Real-World Ambispective Study From India. [PDF]

Cureus
Pradhan A, Panchal HP.
europepmc   +1 more source

Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma. [PDF]

Am J Hematol
Smith SD, Sundaram S, Giri S, Ness A, Wang Y, Gopal AK, Pang Y, Tatoian ET, Grossfeld T, Lynch RC, Warren EH, Nowakowski GS, Park SI.   +12 more
europepmc   +1 more source

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia. [PDF]

Blood Adv
Furman RR, Wierda WG, Patten PEM, Chaves JM, Brown JR, Munir T, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos JC, Patel K, Woyach JA, de Borja M, Wang MH, Jain N, O'Brien SM, Byrd JC.   +17 more
europepmc   +1 more source

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update. [PDF]

Intern Med J
McKeague S, Czerwinski JK, Badoux X, Bennett R, Best G, Chia N, Cochrane T, Crassini K, Cull G, Di Ciaccio P, Fedele P, Harrup R, Jackson S, Kuss B, Lasica M, Lee D, Lew T, Marlton P, Menzies Wojtowicz M, Opat S, Ratnasingam S, Seymour JF, Talaulikar D, Tam CSL, Weinkove R, Wight J, Mulligan S, Anderson MA.   +27 more
europepmc   +1 more source

Treatment of Cold Agglutinin Syndrome Secondary to Chronic Lymphocytic Leukemia With Sutimlimab and Obinutuzumab-Venetoclax. [PDF]

Case Rep Hematol
Lap CJ, Broome CM.
europepmc   +1 more source

Cardiovascular Toxicity of BTKi in Chronic B-Cell Malignancies. [PDF]

Rev Cardiovasc Med
Gan H, Lin J, Sun Q, Xu J, He Q, Chen S, Feng Y, Hu B, Wang W.   +8 more
europepmc   +1 more source

Infectious adverse events associated with novel Bruton tyrosine kinase (BTK) inhibitors in adults with chronic lymphocytic leukaemia: A meta-analysis of randomized controlled trials. [PDF]

Br J Haematol
Janc JJ, Wróbel T, Feliniak N, Kalicińska E.   +3 more
europepmc   +1 more source

First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs. [PDF]

Clinicoecon Outcomes Res
Perrone V, Innao V, Mazzoni S, Cappuccilli M, Andretta M, Bartolini F, Chinellato A, Dell'Orco S, Ferrante F, Lombardi R, Pagliaro R, Ubertazzo L, Valpondi P, Degli Esposti L.   +13 more
europepmc   +1 more source

First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma. [PDF]

Curr Oncol
Puckrin R, Villa D, Fleury I, Larouche JF, Kuruvilla J.   +4 more
europepmc   +1 more source